January 30, 2007 - A novel type of contrast-enhanced magnetic resonance angiography (MRA) is reportedly highly accurate in identifying blockages in the arteries that carry blood to the brain, according to a study in the February issue of Radiology.

“Contrast-enhanced MR angiography provided highly accurate information about the supra-aortic arteries,” said Kambiz Nael, M.D., research fellow and radiology resident at the David Geffen School of Medicine at UCLA in Los Angeles . “MR angiography produced results comparable to the gold standard of digital subtraction angiography (DSA) and multidetector computed tomography (CT) angiography. In addition, this technology produced images with higher resolution over a larger field of view in a shorter amount of time than previous contrast-enhanced MR angiography techniques,” he said.

Arterial occlusive disease consists of narrowed or blocked arteries. It commonly affects the supra-aortic arteries, which supply blood to the brain, and is a leading cause of stroke. Currently DSA is the reference standard for evaluating these arteries. However, in 2.5 percent of cases DSA can cause a mini-stroke, and, in rare instances, permanent neurological damage. Therefore, CT and MR angiography are increasingly being used to diagnose arterial occlusive disease. As technology has improved, MR angiography offers advantages over CT, particularly because it delivers no ionizing radiation to the patient.

“MR angiography, using a small quantity of MRI dye injected into a vein in the arm, can produce detailed images of the arteries supplying the brain and can detect even minor degrees of narrowing or blockage. It does not involve exposure to x-rays and is widely regarded as a very safe, painless test,” Dr. Nael said.

The researchers studied 80 patients (44 men and 36 women) with suspected arterial occlusive disease to compare the performance of contrast-enhanced MR angiography to DSA and CT angiography. Two independent readers evaluated the images. Blockages were detected with MR angiography in 208 (reader 1) and 218 (reader 2) segments of artery, which correlated significantly to the DSA and CT findings. In addition, MR angiography proved highly accurate (94 to 100 percent) for detecting blockages of over 50 percent, and image quality was rated sufficient to excellent for 97 percent of the arterial segments evaluated.

“This procedure should be highly cost effective for clinical use, because of the speed and modest dose of contrast required,” Dr. Nael said. “In the absence of contraindications to MRI, I would recommend MR angiography over DSA and CTA for routine use—avoiding increased risk of mini-stroke and radiation exposure.”

Dr. Nael predicts that in most cases, contrast-enhanced MR angiography could replace other diagnostic techniques for evaluation of all the arteries that supply blood to the brain.

“As the technology evolves, MR angiography will likely become even faster and more powerful,” he said.

Source: Radiology, a monthly scientific journal devoted to clinical radiology and allied sciences. The journal is edited by Anthony V. Proto, M.D., School of Medicine , Virginia Commonwealth University, Richmond , Va. Radiology is owned and published by the Radiological Society of North America, Inc. (RSNA.org/radiolgyjnl)

The Radiological Society of North America (RSNA) is an association of more than 40,000 radiologists, radiation oncologists, medical physicists and related scientists committed to promoting excellence in radiology through education and by fostering research, with the ultimate goal of improving patient care. The Society is based in Oak Brook , Ill. (RSNA.org)

“MR Angiography of Supraaortic Arteries.” Collaborating with Dr. Nael were J. Pablo Villablanca, M.D., Whitney B. Pope, M.D., Ph.D., Thomas O. McNamara, M.D., Gerhard Laub, Ph.D., and J. Paul Finn, M.D.


Related Content

Feature | Radiology Business

Beginning this spring, ITN will begin sending out a bi-monthly survey to our readers on a variety of topics, which we ...

Time May 02, 2024
arrow
News | FDA

April 29, 2024 — The U.S. Food and Drug Administration (FDA) announced Elekta Instrument AB is recalling Disposable ...

Time April 29, 2024
arrow
News | PET Imaging

April 24, 2024 — A new study from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare ...

Time April 24, 2024
arrow
News | Radiology Business

April 23, 2024 — A diverse writing group, led by authors at the University of Toronto, have developed an approach for ...

Time April 23, 2024
arrow
News | Radiology Business

April 17, 2024 — VISTA.AI announced the appointment of Daniel Hawkins as President and CEO. The company is pioneering AI ...

Time April 17, 2024
arrow
News | Radiology Business

April 4, 2024 — FUJIFILM Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging ...

Time April 04, 2024
arrow
News | Molecular Imaging

March 29, 2024 — Magnetic resonance imaging (MRI) is a cornerstone in the landscape of medical diagnostics, celebrated ...

Time March 29, 2024
arrow
News | FDA

March 27, 2024 — SyntheticMR announced that its next-generation imaging solution, SyMRI 3D, has received FDA 510(k) ...

Time March 27, 2024
arrow
News | Artificial Intelligence

March 1, 2024 — Royal Philips, a global leader in health technology, and magnetic resonance imaging (MRI) software ...

Time March 01, 2024
arrow
News | Cardiac Imaging

February 12, 2024 — According to the American Journal of Roentgenology (AJR), free-breathing cine-deep learning (DL) may ...

Time February 12, 2024
arrow
Subscribe Now